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Stable maintenancetheir productive life cycle in stratiﬁed epithelium or mucosa, where the
undifferentiated proliferating keratinocytes are the initial targets for the productive viral infection.
Papillomaviruses have evolved mechanisms to adapt to the normal cellular growth control pathways and
to adjust their DNA replication and maintenance cycle to contend with the cellular differentiation. We
provide overview of the papillomavirus DNA replication in the differentiating epithelium and describe the
molecular interactions important for viral DNA replication on all steps of the viral life cycle.
© 2008 Elsevier Inc. All rights reserved.IntroductionPapillomaviruses (PVs) establish their productive life cycle exclu-
sively in stratiﬁed epithelium of skin or mucosa. These tissues are
complex, composed of several different cell types, majority of which
comprise layered sheets of keratinocytes in various stages of
differentiation. The remaining up to 20% cells include melanocytes,
Langerhans cells and Merkel cells. There are two types of dividing
keratinocytes in the epidermis— slowly cycling undifferentiated stem
cells, and the cells capable of transient proliferation in basal cell
compartment. These undifferentiated proliferating keratinocytes,
presumably stem cells, are the initial target for productive PV
infections and establishment of latent infection. Some of the infected
cells loose the contact with the basal membrane and move up into the
suprabasal compartment of proliferating cells, where they establish
latently infected proliferating cell population. Subsequent steps in the
viral life cycle are strictly dependent on the differentiation of the host
epithelium. During the normal skin development, uninfected kerati-
nocytes exit the cell cycle and commit to the terminal differentiation
ultimately leading to the programmed cell death. Therefore PVs have
evolved mechanisms to adapt to the normal cellular growth control
pathways and adjust their DNA replication cycle and maintenance
cycle to contend with all different cell states. Supported by various
data, the triphasic replication model has been proposed for PVs. The
successful infection of a keratinocyte triggers the initial ampliﬁcation
of PV DNA copy number. This is followed by the stable maintenance
phase of the HPV genome per cell. Finally, vegetative ampliﬁcation of
the viral DNA is performed. We do not know the precise mechanismsll rights reserved.responsible for the switch from one replication mode to another,
however, it seems to be closely bound upwith the differentiation state
of the cells. The second ampliﬁcation round in a subset of spinous cells
results in the synthesis of viral capsid proteins and assembly of virus
particles that are ultimately shed from a small number of superﬁcial
cells during desquamation. The HPV replication cycle takes at least
3 weeks, as this is the time required for the keratinocyte to undergo
complete differentiation cycle.
Infection with the high risk human papillomaviruses may lead to
pathological changes in the infected tissues, like induction of cervical
carcinoma. It has been demonstrated that in most of the cases high
risk HPV subgenomic fragments are found to be integrated into the
host cell chromosomal DNA. The experimental data indicate that over
some transit period the integrated HPV subgenomic fragments, which
carry functional viral replication origin, co-exist with the HPV
plasmids in the same cell. Therefore DNA replication starting from
the integrated replication origin and extending to ﬂanking sequences,
triggered by the E1 and E2 proteins, may induce ampliﬁcation of the
HPV integration locus, which should be the target for the cellular
repair/recombination machinery. As discussed later, ampliﬁcation of
the HPV integration locus induced by the papillomavirus replication
proteins and replication origin may be the actual mechanism for the
genomic instability of the host cell leading to formation of cancer cell.
Initial ampliﬁcation
Signiﬁcant part of the knowledge about the early steps in the PV
replication cycle is based on the bovine papillomavirus type 1 (BPV-1)
due to its ability to infect the C127 cell-line of mouse ﬁbroblasts and to
establish extrachromosomal multicopy nuclear maintenance replica-
tion in these cells. Since the replication mechanisms of the viral
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data available about the human PVs, we can safely extrapolate this
knowledge, with slight modiﬁcations, to the majority of PVs (Berg and
Stenlund, 1997; Chiang et al., 1992; Del Vecchio et al., 1992; Sverdrup
and Khan, 1994).
The infection, uncoating and entry of PV DNA into the cell nucleus
is followed by the activation of the promoter on it in the upstream
regulatory region that initiates expression of the early proteins. Two of
them, the E1 and E2, direct the host cell replication factors to the viral
origin of replication, resulting in the initial quick rise of the viral
genome copy number per cell. Thus, the initial ampliﬁcation of the
viral genome can be simply modelled in cell culture by transient
transfection of the E1 and E2 expression vectors together with the
reporter plasmid carrying the sequences of the viral replication origin
(Chiang et al., 1992; Frattini and Laimins, 1994; Sverdrup and Khan,
1994; Ustav et al., 1993, 1991; Ustav and Stenlund, 1991). The
replication of the PV origin containing template has also been
reconstituted in vitro by several groups with puriﬁed E1 and E2
proteins and extracts from mammalian cells (Bonne-Andrea et al.,
1995; Kuo et al., 1994; Melendy et al., 1995; Muller et al., 1994; Yang et
al., 1991). The in vitro experiments have demonstrated that the E1
protein is responsible for the melting of the DNA at viral origin as well
as for subsequent unwinding of the double helix during replication
fork progression (Sedman and Stenlund, 1998; Yang et al., 1993). The
full length E2 is a transcription activator that has an auxiliary role
during the initiation of the DNA replication, where it acts as a
speciﬁcity factor for E1 (Bonne-Andrea et al., 1997; Sedman and
Stenlund, 1995). Papillomaviruses have been shown to encode also
mRNAs for the short forms of the E2 proteins that maintain their DNA
binding domain but lack the activation domain. The heterodimers
composed of the full-length BPV-1 E2 and E2C can effectively activate
DNA replication, indicating that the single activation domain is
sufﬁcient for facilitating the E1 protein loading on the origin (Kurg
et al., 2006; Lim et al., 1998).
Initiation of the replication of PV genome starts with the origin
recognition that involves the cooperative binding of E1 and E2 dimers
to the viral origin (Chiang et al., 1992; Kurg et al., 2006; Russell and
Botchan, 1995; Stenlund, 2003b; Sverdrup and Khan, 1994; Ustav et
al., 1993; Ustav and Stenlund, 1991), which is located within the
upstream regulatory region (URR) of the genome and contains binding
sites for the E1 and E2 proteins as well as AT-rich area (Remm et al.,
1992; Ustav et al., 1991). Full-length E1 protein has a low sequence
speciﬁcity and therefore it can initiate DNA replication in vitro as well
as from non-speciﬁc DNA sequence in the absence of E2 protein
(Bonne-Andrea et al., 1995, 1997; Sedman and Stenlund, 1995).
However, in in vivo assays, there is an absolute requirement for the
E2 protein to initiate the viral DNA replication (Ustav and Stenlund,
1991). The low speciﬁcity of E1 is a sum of the binding properties of its
two different domains: DNA binding through the DNA binding domain
(DBD) of the E1 is highly sequence speciﬁc and DNA binding through
the E1 helicase domain is sequence non-speciﬁc (Stenlund, 2003a). It
has been also shown that the role of the E2 protein as a speciﬁcity
factor is fulﬁlled through its ability to inhibit the non-speciﬁc DNA
binding of the E1 helicase domain. Binding of the E1 and E2 to the viral
origin is proposed to be followed by recruitment of the second E1
dimer and release of the E2 in an ATP-dependent manner (Chen and
Stenlund, 2002; Enemark et al., 2002; Sanders and Stenlund, 1998). In
the next step, the E1 tetramer is converted to the head-to-head copies
of E1 double trimer (DT), inwhich the E1molecules are positioned in a
helical arrangement at dsDNA with the offset of 3 bp relative to each
other (Schuck and Stenlund, 2005). The E1 double trimer itself is a
precursor for the formation of the active E1 double hexamer (DH),
which is accompanied by the transition from a helical arrangement to
a ring structure without dissociation of the E1-DNA contacts.
Interestingly, as indicated by the X-ray crystal structures of the
oligomerization and helicase domains of BPV-1 E1 protein, the E1hexamers are binding to the ssDNA (Enemark and Joshua-Tor, 2006).
The exact mechanisms of the ﬁnal transitions from dsDNA-bound DT
to the ssDNA-bound hexameric E1 helicase is not entirely understood,
but the general picture starts to emerge. It is known that the formation
of DT is very fast compared to subsequent formation of DH, whichmay
reﬂect the continuous modiﬁcation of the DNA structure, while the
new E1 molecules are added to the DT. Correspondingly, it has been
published that after the formation of DT, histidine H507 of the highly
conserved β-hairpin of the E1 helicase domain intercalates into the
minor groove of the DNA and causes the local melting of the viral
origin, which is prerequisite for the formation of a DH (Schuck and
Stenlund, 2005; Schuck and Stenlund, 2007). Along with this model,
DH is assembled speciﬁcally to one of the melted strands by the
recruitment of additional E1monomers and through the interaction of
the β-hairpin with ssDNA (Liu et al., 2007b). Although it is not clear
whether the E1 functions as a single hexamer, moving on the
template, or as a stationary double hexamer pumping ssDNA through
itself, the structural data suggest the “coordinated escort”mechanism
of DNA translocation while the ssDNA passes through the E1 helicase
(Enemark and Joshua-Tor, 2006). According to the model, β-hairpin of
each E1 subunit, upon binding an ATP molecule, picks up the next
available nucleotide in ssDNA and escorts it through the hexamer
channel via ATP hydrolysis and subsequent ADP release. It is like
climbing on a rope with six hands in a hand-over-hand manner.
Recruitment of the host cell replication proteins by the viral pre-
replication complex is not so thoroughly studied and merely the
interaction of the E1 with replication protein A, topoisomerase and
polymerase α-primase has been reported (Clower et al., 2006; Han et
al., 1999; Melendy et al., 1995; Park et al., 1994). Phosphorylation by
cyclinE/Cdk2 and cyclinA/Cdk2 complexes are important for E1
nuclear localization (Deng et al., 2004; Hsu et al., 2007). It is also
known that the various combinations of E1 and E2 proteins from
different PVs can initiate DNA replication from several different PV
origins (Chiang et al., 1992; Del Vecchio et al., 1992; Kadaja et al., 2007;
Sverdrup and Khan, 1994).
Stable maintenance replication
The ﬁrst ampliﬁcational replication is believed to be rapid and
transient, after which the viral DNA is stably maintained at an almost
constant copy number during the subsequent divisions of the basal
cells. This is thought to be achieved by the maintenance replication,
where the viral genomes approximately double during the S-phase of
the host cell cycle and almost equally segregate into the nucleuses of
two daughter cells.
There are two possible modes for the viral maintenance replica-
tion. The ﬁrst is that the DNA replicates like the cellular DNA, once per
S-phase. Thus, DNA replication initiation from the viral replication
origin is strictly controlled by the host cellular factors - this type of
replication is described for Epstein–Barr virus (EBV) latent replication
origin oriP (Adams, 1987). Some authors have been suggested that PV
DNA replication during the stable maintenance period follows an
ordered “once per cell cycle” fashion and relies entirely on the host cell
replication factors (Botchan et al., 1986; Hoffmann et al., 2006; Kim
and Lambert, 2002; Roberts and Weintraub, 1988). Others provide
evidence that PV DNA replicates randomly, initiation from the viral
replication origin is not rigidly regulated; whereby some molecules
replicate a few times per S-phase, some replicate once, and some do
not replicate at all (Gilbert and Cohen, 1987; Piirsoo et al., 1996;
Ravnan et al., 1992). Both scenarios could in theory maintain the viral
DNA roughly at the same copy number throughout the proliferative
phase of the host cell. It is generally accepted that the DNA replication
initiation process during the stable maintenance of full-length BPV1
genomes as well as its URR reporter plasmids are guided by relaxed
random-choice control mechanisms that results in statistically “once
per cell cycle” replication of the viral DNA (Piirsoo et al., 1996; Ravnan
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HPV replication. The data have been published that HPV16 DNA
replicates in a once-per-S-phase manner in W12 cells; while HPV31
DNA replicated randomly in CIN612 cells. Even more, both viruses
replicated random-choice way in an alternative keratinocyte cell line
NIKS. This observation shows that HPV DNA replication by either
random choice or once-per-S-phase fashion may be dependent on the
cell types that carry the viral episome. It is notable that the switching
between different replication modes seems to be dependent of the E1
protein expression level. At higher expression levels of the E1 protein
the HPV16 DNA replicated randomly also in W12 cells (Hoffmann
et al., 2006). The basal epithelium consists of the stem cells and
transit-amplifying cells. It is plausible that the HPV DNA, entered into
these two dissimilar cell types by infection, may replicate differently.
However, exclusive extrachromosomal nature of the HPV genomes
should be demonstrated in the cell lines, where the “once per cell
cycle” mode of DNA replication is detected. The signals from the
integrated HPV genomes may give false indications, as it has been
shown for the BPV1 (Ravnan et al. 1992).
It is still widely accepted that the E1 and E2 proteins are essential
for long-term stable replication. Studies with BPV1 have been
demonstrated that the E1 protein is essential for the ﬁrst establish-
ment of viral genome as a nuclear plasmid in BPV1 transformed C127
cells and the E1 protein supports the long-term maintenance of BPV1
genome as a nuclear plasmid (Dvoretzky et al., 1980; Law et al., 1981;
Rabson et al., 1986). Some studies suggest that the E1 protein is
needed only to establish viral genome as nuclear plasmid, but is not
required later on maintenance stage of the viral life cycle (Kim and
Lambert, 2002). Furthermore, the expression of the fully functional
viral oncoproteins E6 and E7 has been shown to be also necessary for
the maintenance of the extrachromosomal forms of HPV DNA
(Thomas et al., 1999). These oncoproteins may create a cellular
environment, conducive to HPV maintenance and abrogate the
checkpoints that block the long-term retention of extrachromosomal
DNAs (Garner-Hamrick et al., 2004; Howley and Lowy, 2001; Thomas
et al., 1999).
Experiments in budding yeast Saccharomyces cerevisiae have
demonstrated that under certain conditions some of the HPV genomes
can be replicated and stably maintained in the absence of any
particular viral protein, inclusively the E1 and E2 (Angeletti et al.,
2002; Kim et al., 2005; Rogers et al., 2008). Recently, the E1 and E2-
independent mode of DNA replication and maintenance of HPV16
were also described in mammalian cells (Rogers et al., 2008). The
uptake of the BPV-1 virions as well as genome replication has also
been demonstrated in Saccharomyces cerevisiae (Angeletti et al., 2002;
Zhao and Frazer, 2002a, 2002b). Later studies have been indicated,
though, that the BPV genomes are not stably maintained in Sacchar-
omyces cerevisiae (Angeletti et al., 2002).
There is still no clear evidence of the cis-elements that contribute
to the E1-independent DNA replication as well as any demonstrations
of involvement of the cellular pre-replication complexes (pre-RC) in
the initiation of the PV DNA replication during its stable maintenance
in mammalian cells – like in case of EBV (Chaudhuri et al., 2001; Dhar
et al., 2001). Instead, the 2D analysis of the replication intermediates
of BPV1, HPV11 and HPV16 in cells that stably maintain the viral
genome, have mapped the origin of replication to the same part of the
URR fragment that is used for E1-E2-dependent initiation of DNA
replication (Auborn et al., 1994; Flores and Lambert, 1997; Schvartz-
man et al., 1990; Yang and Botchan, 1990).
It is clear that the E2 protein is a central player of PV life cycle as it
is for stable maintenance process. Although, the E2 of BPV1 has been
characterized as transcription activator (Spalholz, Yang, and Howley,
1985), it is a multifunctional protein also involved in viral DNA
replication and in maintenance process. The full-length E2 protein
contains two conserved functional domains: the N-terminal transac-
tivation domain (TAD) and the C-terminal domain (DBD) for DNA-binding and dimerization. These domains are linked by the ﬂexible
hinge region. In addition to full length E2 protein, two shorter
repressor forms have been described. For BPV1, mRNA for E2C is
transcribed from the promoter internal to the E2 open reading frame;
and the E8/E2 is created by splicing. The repressor forms lack the
activation domain and are not able to activate transcription and
replication from the E2 binding site-dependent promoters; however,
they share common DBDs and are able to form dimers and
heterodimers (McBride et al., 1989). Genetic analyses of BPV1 mutants
lacking the expression of the repressor forms of E2 protein, E8/E2 or
E2C, replicated at 10- to 20-fold higher DNA copy number in
transformed cells, suggesting that repressors may negatively regulate
the viral DNA replication (Lambert et al., 1990; Riese et al., 1990). The
mutants where expression of both repressor forms of E2 were
eliminated replicated even more efﬁciency, however, stable episomal
replication of the viral genomes was not detected. This suggests that
although repressor form negatively regulates the viral genome
replication, their action is needed for stable replication. The E2-E2C
heterodimers support papillomavirus DNA replication and efﬁciently
activate the E2-dependent promoters but are inactive in segregation
function (Kurg et al., 2006).
The E8 domain encoded by HPV31 consists of only 12 amino acids
and has no sequence homology to TAD of E2. The E8/E2C protein is a
strong negative regulator of PV DNA replication. HPV31 mutant
genomes that carry disturbed expression for E8/E2C demonstrate an
over-replication phenotype, suggesting that the E8/E2C restricts
HPV31 copy number in undifferentiated keratinocytes. Despite being
as a negative regulator, the E8/E2C is required for the long-term
maintenance of HPV31 episomes in normal human keratinocytes
(Stubenrauch et al., 2000). However, an alternative study shows that
the HPV16 E8/E2C represses HPV16 plasmid ampliﬁcation, but is not
required for plasmid persistence and maintenance (Lace et al., 2008).
The E8 domain is responsible for the interaction with several cellular
co-repressor molecules such as histone deacetylases, histone methyl-
transferase SETDB1, and TRIM28. Whereas only the interaction with
TRIM28 has been veriﬁed to be involved in inhibition of the E1/E2
dependent replication (Ammermann et al., 2008).
Segregation of the PV DNA into daughter cells during the stable
maintenance process
The replicated PV episomes must ensure nearly equal segregation
of their extrachromosomal genomes into daughter cells during cell
division. This process is mediated through E2 protein and its binding
sites within the URR region, known as minichromosomemaintenance
element (MME) (Piirsoo et al., 1996). MME is comprised of at least six
E2 binding sites in the plasmid. MME and E2 are responsible for
anchoring of full-length PV genomes as well as URR reporter plasmids
to host cell chromosomes, and this process is believed to ensure the
partitioning of viral extrachromosomal DNA molecules during the
host cell division (Ilves et al., 1999; Lehman and Botchan, 1998;
Skiadopoulos and McBride, 1998; You et al., 2004). Human papillo-
maviruses carry not more than four E2 binding sites, therefore the
same mechanism as described for the BPV1 is not necessarily used for
HPV maintenance. It has been demonstrated that the E2 proteins of
HPV-11, -16 and -18 localize to the mitotic spindles instead of mitotic
chromosomes (Van Tine et al., 2004). It is interesting to note that C-
terminal part of HPV11 E2 protein is critical for the localization to the
mitotic spindle, whereas N-terminal part of BPV1 E2 is responsible for
chromatin attachment (Van Tine et al., 2004). Association with the
mitotic chromosomes as a mechanism for viral DNA segregation is not
unique for BPV1. Very similar strategy has previously been described
for EBV and Kaposi's sarcoma virus (KSHV). EBV uses the virus-
encoded nuclear antigen 1 and KSHV latency-associated nuclear
antigen 1 proteins as anchoring proteins (Ballestas et al., 1999; Wu
et al., 2000).
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maintenance process. Recently it was shown that the cellular
bromodomain protein Brd4 interacts with BPV1 E2 and it was
proposed that Brd4 is a receptor for E2 on mitotic chromosomes
(You et al., 2004). Even more recent study indicated that all E2
proteins from different PV types interact with Brd4; albeit, interaction
efﬁciency is varying (McPhillips et al., 2006). In the same study, it was
shown that some of PVs E2 proteins did not co-localize with Brd4 on
host mitotic chromosomes. Brd4-independent chromatin attachment
was described for alpha PVs; therefore it is possible that these E2
proteins use a cellular binding target other than Brd4 to mediate their
association with mitotic chromosomes (McPhillips et al., 2006).
Recently it has been demonstrated that human protein ChlR1
(chromosome loss-related protein 1) interacts with HPV11, -16 and
BPV1 E2 proteins and performs as tethering factor for BPV-1 genomes
(Parish et al., 2006).
We can conclude that Brd4 is involved in multiple processes of PV
life cycle through interactions with E2 protein. Several independent
groups have shown that Brd4-E2 interaction is required for the
transactivation function of E2 (Ilves et al., 2006; McPhillips et al.,
2006; Schweiger et al., 2006; Senechal et al., 2007). The C-terminal
domain of Brd4 binds E2, and with its N-terminal bromodomain, Brd4
interacts with positive transcriptional elongation factor P-TEFb (cyclin
T1/Cdk9) (Yang et al., 2005) and displaces an inhibitory subunit (7SK
snRNA and MAQ1/HEXIM1) from the P-TEFb complex; thereby,
transforming P-TEFb into its transcriptionally active form. Brd4 acts
as enhancer to recruit P-TEFb to hindered polymerase II and
stimulates phosphorylation of its CTD by P-TEFb, thereby increasing
polymerase II-dependent transcription of E2-dependent promoters
(Schweiger et al., 2007; Wu and Chiang, 2007).
It is known that apart from the E2 protein transactivation function
in case of HPVs, E2 also participates in transcription repression
complexes and inhibits expression of the viral E6 oncoprotein, which
in turn, regulates p53 target gene transcription. Recently, two groups
have studied Brd4 functions in transcription repression complexes.
Wu et al. used biochemical in vitro assays and low-risk HPV11 E2
protein to show that Brd4 is a component of the virus-assembled
transcriptional silencing complex (Wu et al., 2006). In contrast,
Schweiger et al. showed Brd4-independent mechanism of E2-
mediated repression in cell-based in vivo assays (Schweiger et al.,
2007). It seems that Brd4 is one of the major components in E2
mediated transcription activation; however, the role of the Brd4 in E2
mediated silencing and exact functions in maintenance process needs
further investigation.
There is some evidence that Brd4 also inﬂuences to PV replication.
Ectopic over expression of the E2-binding C-terminal domain (CTD) of
Brd4, a dominant-acting negative inhibitor of Brd4/E2 binding,
inhibited the transient replication of BPV1 genome (Ilves et al.,
2006). Brd4 CTD inhibits BPV1 DNA replication independently of its
binding to E2 in a cell line speciﬁc mode (Ilves et al., 2006; Schweiger
et al., 2006).
Vegetative ampliﬁcation
Normal stratiﬁed squamous epithelial cells exit the cell cycle and
stop dividing as soon as they detach from the basement membrane.
Problem for PVs is that the necessary cellular DNA polymerases and
replication factors are only produced in mitotically active cells.
Molecular mechanisms to disconnect of keratinocyte differentiation
from cell cycle arrest, as well as to maintain or re-establish a
replication-competent state within terminally differentiated kerati-
nocytes are not well understood, but the interactions of virus-encoded
oncogenes with variety of host regulatory proteins seem to play the
central role (Boyer et al., 1996; Dyson et al., 1989; Jeon et al., 1995;
Romanczuk and Howley, 1992; Scheffner et al., 1990; Werness et al.,
1990). The functions of E6 and E7 are to subvert pathways that signalgrowth arrest during differentiation and to establish and/or maintain
a cellular milieu that supports viral genome replication (Cheng et al.,
1995; Stubenrauch and Laimins, 1999). The viral oncogenes could
disturb the cell-cycle control checkpoints by abrogating the regulation
of family of cyclins, cyclin-dependent kinases (cdks), and cdk
inhibitors (Funk et al., 1997; Jones et al., 1997; Zerfass-Thome et al.,
1996).
Differentiation-dependent viral DNA replication is proposed to be
regulated at transcriptional level (Bedell et al., 1991). There is a tight
linkage of viral late-gene expression with epithelial differentiation
and a massive up-regulation of viral gene expression from the late
differentiation-dependent promoters in the infected epithelium
(Grassmann et al., 1996; Hummel et al., 1992; Ozbun and Meyers,
1998a; Ozbun and Meyers, 1998b). If the PV infected cells reach the
suprabasal level of differentiated epithelium, the transcription of
HPV16 and -31 E1 and E2 genes are switched from the E2-regulated
early promoter to the E2-independent late promoter located within
the E7 ORF, resulting in high levels of the E1 and E2 (Grassmann et al.,
1996; Klumpp and Laimins, 1999). Molecular mechanisms leading to
the activation of the late differentiation-dependent promoter are not
understood. Therefore it is possible that the promoter is constitutively
active and PV protein expression is regulated by alternative splicing
patterns in epithelial cells at different differentiation stages. Alter-
native splicing could explain the up-regulation of HPV18 protein
expression in differentiated keratinocytes, since there is no late
promoter found inside the HPV18 E7 ORF. Currentmodels suggest that
the increased levels of E1 and E2 (and probably E4 and E5) result in
subsequent increase in viral copy number up to thousands per cell.
Although there are no solid data available in the literature, it is
plausible that the bi-directional semi-conservative DNA replication
takes place in the differentiating cells. There are two papers
suggesting that BPV-1, HPV16 and HPV31 might switch their
replication to the rolling circle mode at this stage of their life cycle
(Dasgupta et al., 1992; Flores and Lambert, 1997). Flores and Lambert
made their conclusions based on the inability to detect the bubble and
double-Y-shaped DNA replication intermediates of HPV16 and HPV31
genomes in differentiated cells. However, the study remains incon-
clusive, since in case of the rolling circles, very characteristic
additional patterns should appear in two dimensional gels, like it
has been demonstrated by the well-characterized T4 in vitro
replication system (Belanger et al., 1996). One of these is ds-eyebrow,
which has never been detected while the PV replicons have been
analyzed. In another study, Dasgupta et al. performed the electron-
microscopic analysis of the low molecular weight DNA from the
mouse cells harbouring high levels of BPV-1 genome. While the
structures of the observed molecules were consistent with the rolling
circles, neither the BPV-1 speciﬁcity was proven nor were presented
negative control samples without BPV-1 genome. Therefore, we
conclude that further studies are needed to reveal the viral replication
mode in this phase of the PV replication cycle.
Regardless of the exact mechanism of viral replication, the ﬁnal
vegetative PV ampliﬁcation is followed by the expression of L1 and L2
structural proteins and assembly of virions in the upper layers of
infected tissue. Since PVs are non-lytic, they are not released until the
infected cells reach the epithelial surface.
Aberrant viral DNA ampliﬁcation. The ‘’onion-skin’’ type of
replication (OSR)mode and potential link to HPVgenome instability
Analyzing the E1-dependent replication mode of the BPV-1
genome, we have been made an important observation about the
switch of themode of the BPV-1 DNA replication (Mannik et al., 2002).
Elevated E1 protein levels facilitate too efﬁcient initiation of replica-
tion compared to the elongation of the DNA synthesis. Such
replication mode can be characterised by the “onion-skin”-type of
replication (OSR) model, previously described by others (Botchan et
364 Minireviewal., 1979; Bullock et al., 1984; Hanahan et al., 1980; Syu and Fluck,
1997). This aberrant replication mode generates a complicated set of
partially replicated fragments of the BPV1 genome, enriched with
branching DNA strands, partially single stranded or double stranded,
and abundant linear fragments, actively modiﬁed, recombined and
degraded by the cellular machinery. Such OSR intermediates have still
open regions carrying active replication origins capable of initiation of
DNA replication. The amount of the subgenomic fragments depends
on E1 protein concentration. We showed that at the high E1 levels
more than 99% of the replication signal can be found in the linear
fragments (Mannik et al., 2002). Therefore too intensive initiation of
viral DNA replication at high E1 levels may threaten the intactness of
viral genome.
It has been clearly established that high-risk PVs (subtypes 16, 18,
31, etc) are etiological agents for cervical carcinoma. Tumour
progression in HR-HPV-associated neoplasia is marked as a low-
grade squamous intraepithelial lesion (LSIL), a high-grade squamous
intraepithelial lesion (HSIL) or an invasive squamous cell carcinoma
(SCC). The physical state of the HPV genome in these different states of
neoplastic tissues has been evaluated in several studies over the past
few decades. However, only the recent development of quantitative
real-time PCR protocols have provided reliable sensitivity needed to
understand the physical state of HPV in these tissues (Andersson et al.,
2005; Arias-Pulido et al., 2006; Kulmala et al., 2006; Peitsaro et al.,
2002b; Yoshida et al., 2008). Based on these data it can be concluded
that although the viral load in tissue samples decreases from LSIL to
SCC, the frequency of HPV integration increases according to the
degree of transformation. More than 95% of the cases of cervical
carcinoma, the genome of high-risk HPVs have been found to be
present, and in most of these cases, the viral genome has been
integrated into the host cell genome, usually through L1 and E1 ORF
regions. These integrated genome fragments very much resemble the
fragments generated by ampliﬁcational replication at high concentra-
tions of E1 protein. We have identiﬁed the similar replication mode
also among the human PVs (Kadaja et al., 2007). Our preliminary data
show that the OSR is characteristic for both, low- and high-risk human
PVs, though E1 and E2 proteins from the high-risk viruses induce this
type of replication at lower E1 protein concentrations and more
efﬁciently.
Papillomavirus replication induced genomic instability
Studies, where the physical state of HPV genome have been
analysed, indicate that the HPVDNA integration is a very early event in
cervical carcinogenesis resulting in a situation where the mixed
(episomal and integrated) pattern is the most prevalent state of HPVs
already in PAP smears with normalmorphology or with LSIL. Although
the presence of episomal and integrated HPV within the same cells in
clinical samples has not been studied recently, some earlier studies
have observed this using in situ hybridization (Cooper et al., 1991;
Kristiansen et al., 1994). In addition, experiments using the HPV16-
positive W12 cell line demonstrated the initial co-existence of
episomal and integrated HPV16 DNA in the same cells in early
passages resulting in the loss of the HPV plasmids in later passages
(Pett et al., 2006). Similar results were obtained with a cell line
carrying HPV33 (Peitsaro et al., 2002a). There are no preferred
breakpoints inside the integrated HPV sequence, however; the E1 and
E2 ORFs are disrupted consistently and the E6, E7 ORFs as well as the
URR are present (Baker et al., 1987; Kalantari et al., 2001; Luft et al.,
2001; Peter et al., 2006; Ziegert et al., 2003; Wagatsuma et al., 1990).
Despite of that, it is plausible that the E1 and E2 proteins are still
expressed from the HPV plasmid during this intermediate step,
because the episomal DNA replication and the maintenance are
absolutely dependent on these proteins (Piirsoo et al., 1996). Current
models suggest that when the integration occurs the repression
function of E2 is switched off allowing for an increase in theexpression of viral oncoproteins E6 and E7 (Corden et al., 1999;
Kalantari et al., 2001; Peter et al., 2006). E6 and E7 have been shown to
give cells a selective growth advantage due to the increased cell
immortalization achieved primarily by the disruption of the function
of p53 and the retinoblastoma tumour suppressor protein family
members (Boyer et al., 1996; Dyson et al., 1989; Jeon et al., 1995;
Romanczuk and Howley, 1992; Scheffner et al., 1990). This model also
explains the loss of episome, since the E2 protein expressed from the
episomal HPV inhibits the expression of the viral oncoproteins E6 and
E7, thus taking away the growth advantage for these cells (Dowhanick
et al., 1995). Loss of the viral episomes seems to be a common feature
of the DNA viruses, which maintain genomes as extrachromosomal
genetic elements in latently infected cells. In case of BPV1, the loss of
the episome has shown to be in the range of the 6% per cell generation
(Silla et al., 2005).
In eukaryotic cells, the genomic DNA is replicated exactly once per
cell cycle. The prevention of DNA re-replication is guaranteed by the
temporal separation of two critical events: the formation of pre-
replication complex (licensing of replication) and the actual initiation
step of DNA synthesis (Fig. 1) (Blow and Dutta, 2005; Machidaet al.,
2005). If the cellular pre-RCs are re-assembled in S-phase and the
genomic DNA re-replication is initiated, the ATR (the ATM and Rad3-
related kinase) checkpoint pathways are activated and the further
DNA re-replication is prevented (Liu et al., 2007a; Vaziri et al., 2003).
However, when the ATR pathways are not effective and the double
strand breaks (DSBs) are generated, the ATM (ataxia telangiectasia
mutated kinase) pathways are activated to repair the DNA damage. In
principle, the structure of DNA breaks produced by the DNA re-
replication should not differ from other types of DSBs, and therefore
they should be repaired by either non-homologous end-joining
(NHEJ) or homologous recombination (HR).
PVs can amplify their genome in infected cells despite of the
cellular control mechanisms evolved to stop the DNA re-replication. It
might be caused by the differential assembly of viral and cellular pre-
RCs or by the distinctive features of E1 helicase compared to the
putative cellular helicase MCM2-7 (Fig. 1). Up to date, there has been
no evidence published excluding the possibility for the viral pre-RC to
be assembled in S-phase, simultaneously with the initiation of the
viral DNA replication. Instead, it has been published that unlike the
replication of cellular DNA mediated by the ORC and MCM2-7
complexes, the E1- and E2-dependent DNA replication does not
follow the “once per cell cycle” initiation mode in their life cycle
(Piirsoo et al., 1996; Ravnan et al., 1992). We have demonstrated that
BPV-1 has the ability to mask its replication from p53, which inhibits
the replication of several DNA viruses (Ilves, 2003).
Since PVs have evolved mechanisms to avoid cellular control
pathways that would otherwise hinder the DNA re-replication, the
integrated origin of high-risk HPV DNA replication could be an
important characteristic in generating the invasive cervical cancer.
Although the ORFs of the two viral replication proteins are disrupted
during the integration, there is a short period of time, after the initial
HPV integration and before the loss of the HPV episomes, when
functional E1 and E2 proteins are still present in the same cells
(Peitsaro et al., 2002a; Pett et al., 2006). We have demonstrated
recently that the integrated HR-HPV origin is effectively mobilized for
replication by the HPV E1 and E2 proteins, produced from respective
expression vectors, and more importantly, from episomal HPV
genomes transiently replicating in the same cells (Kadaja et al.,
2007). We have observed that the E1- and E2-dependent initiation of
DNA replication from the integrated HPV origin does not follow the
conventional rules of chromosomal DNA replication and does not
guarantee the duplication of the genomic DNA once per cell cycle.
Instead, the E1 together with E2 cause multiple initiations at the
integrated HPV origin in a single S-phase that ultimately leads to the
ampliﬁcation of HPV sequences and affects the ﬂanking cellular
sequences at both sides of HPV integration (Fig. 2). These data provide
Fig. 1. (A) Initiation of the cellular DNA replication The replication of an eukaryotic chromosome starts frommultiple origins that are determined during late S- to early G1- phase of
the cell cycle by the six-protein origin recognition complex (ORC) (DePamphilis, 2005). In late G1-phase, some of the ORCs are chosen to be platforms for pre-replication complex
(pre-RC) formationwhich involves the loading of an inactive form of MCM2-7 helicase complex (MCM2-7) by cdc6 and Cdt1 (Cook et al., 2004; Mailand and Difﬂey, 2005; Rialland et
al., 2002; Yan et al., 1998). In S-phase, DNA replication is activated by the coordinated action of multiple additional proteins (Blow and Dutta, 2005; Jiang et al., 1999; Labib and
Gambus, 2007;Masai et al., 2006;Mendez and Stillman, 2003). At the same time, the pre-RCs themselves are disassembled and the reassociation ofMCMproteins with origins are not
permitted as cdc6 and Cdt1 are inactivated. (B) Initiation of PV DNA replication. Replication of the PV genome is initiated via the viral pre-RC that involves the cooperative binding of
E1 and E2 to the viral origin followed by the hexamerization of E1 and the release of E2. In the next step, the host cell replication proteins are recruited and the E1 protein starts to act
as a DNA helicase. For simplicity, only the components of the pre-replication complex (pre-RC) are presented.
365Minireviewexperimental proof for the hypothesis that similar ampliﬁcation of the
integrated HR-HPV sequences could happen in HPV infected cells in
LSIL and HSIL if episomal HPV genomes producing viral replication
proteins are present.Fig. 2. Proposed model demonstrating how PV replication machinery can induce genomic ins
the DNA re-replication from the integrated HPV origin is initiated. In most of the cases, the
recombination and non-homologous end-joining. However, we have also detected the dup
extrachromosomal copies of HPV locus and the cross-chromosomal translocations (Kadaja eWe have data from the immunoﬂuorescence analysis revealing
that the replication of integrated HPV takes place in the DNA repair/
recombination centres, which incorporates viral and cellular replica-
tion proteins as well as the DNA repair factors: MRE complex, Ku70/80,tability in its host cell. If HPV plasmid is present in the cells harbouring integrated HPV,
cells are going to apoptosis or the damage sites are repaired properly by homologous
lications within the HPV locus (Kadaja et al., 2007), the excision and the generation of
t al., manuscript submitted for publication).
366 MinireviewATM, ATRIP and Chk2 (Kadaja et al., manuscript submitted for
publication). In addition, we have observed the phosphorylation of
histone γH2AX and the activation of Chk2 in the cells harbouring
integrated HPV and expressing the viral replication proteins. Clonal
analysis of the cells, where the replication from integrated HPV origin
was induced, demonstrated the duplication of the HPV containing and
ﬂanking cellular sequences (Kadaja et al., 2007) as well as the de novo
cross-chromosomal translocation (Kadaja et al., manuscript submitted
for publication). Similar translocations of the viral-host DNA have also
been detected in cell lines derived from invasive genital carcinomas
with native expression levels of the viral proteins (Brink et al., 2002;
Couturier et al., 1991; Peter et al., 2006). These results demonstrate
that the replication initiated from the integrated HPV could induce the
activation of DNA repair/recombination systems, which results in
changes in the content of the host cell genome (Fig. 2). The exact
outcome of rearrangements is difﬁcult to predict, but it is reasonable
to assume that modiﬁcations of the genome could affect any number
of oncogenes resulting in a transformation of cells into cancer cells.
The genomic changes may contribute to the transformation directly or
indirectly by increasing expression of viral oncogenes E6 and E7 as
well as effecting the regulation of host genes nearby. Recently it has
been published that cellular regions at the MYC locus, encompassing
HPV sequences, are ampliﬁed in several cell lines derived from
tumours (Herrick et al., 2005). In addition, cytogenetic characteriza-
tion revealed the dispersion and co-ampliﬁcation of c-MYC and HPV18
DNA in HeLa cells (Macville et al., 1999).
There is evidence from previous studies indicating the presence of
different PV subtypes in the same tissue in clinical samples, suggesting
that frequency of co-infections may be quite high (Kulmala et al.,
2006). Therefore we can speculate that cells containing integrated
HPV could also be targets for de novo infection of PVs resulting in an
intracellular mixture of episomal and integrated HPV. This could then
lead to ampliﬁcation of integrated HPV DNA together with ﬂanking
cellular sequences and become a potential threat to the host cell
genomic integrity. This is especially remarkable since we have
demonstrated that low-risk HPVs, which are considered harmless,
have the ability to initiate DNA replication from the integrated HR-
HPV origin (Kadaja et al., 2007).
These data suggest that the interactions between PV replication
machinery and the cellular DNA repair complexes might be respon-
sible for inducing the genomic changes that result ultimately in the
formation of the HPV-associated cancer cells.
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